Moleculin Biotech, Inc. Liquidation Value
MBRX
Other
Cash & Equivalents
$8.88M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $8.88M
Total Obligations: -$7.21M
$1.67M
Per share: $0.52
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $8.88M
AR: $0
Total Obligations: -$7.21M
$1.67M
Per share: $0.52
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $8.88M
AR: $0
Inventory: $0
Total Obligations: -$7.21M
$1.67M
Per share: $0.52
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $1.67M | $0.52 |
| Liquid Liquidation Value | $1.67M | $0.52 |
| Operating Liquidation Value | $1.67M | $0.52 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $8.88M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $6.85M |
| Long-term Debt | N/A |
| Op. Lease Liability | $359,000 |
| Finance Lease | N/A |
| Shares Outstanding | 3.2M |
Explore all 149 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $8.88M | N/A | N/A | $3.51M | $6.85M | N/A | $359,000 | N/A |
| 2025-09-30 | $6.70M | N/A | N/A | $2.12M | $5.68M | N/A | $390,000 | N/A |
| 2025-06-30 | $7.56M | N/A | N/A | $3.72M | $7.91M | N/A | $420,000 | N/A |
| 2025-03-31 | $7.72M | N/A | N/A | $2.71M | $6.90M | N/A | $450,000 | N/A |
| 2024-12-31 | $4.28M | N/A | N/A | $2.03M | $5.36M | N/A | $478,000 | N/A |
| 2024-09-30 | $9.40M | N/A | N/A | $2.55M | $5.59M | N/A | $506,000 | N/A |
| 2024-06-30 | $10.85M | N/A | N/A | $2.83M | $5.75M | N/A | $532,000 | N/A |
| 2024-03-31 | $16.82M | N/A | N/A | $2.10M | $5.41M | N/A | $559,000 | N/A |
▼ Community Notes